Analysts and analyses
Read more:
Analysts following nanologica
REDEYE
Filip Einarsson
Latest analyses and notes:
Nanologica Q2 2025: Low near-term visibility but encouraging long-term case
Nanologica US production evaluation order – 2025-06-12
Nanologica: Mandatory SEK 1 bid from Flerie
Nanologica: Threshold for mandatory bid passed by Flerie Invest – initial comments
Nanologica Q1 2025: Limited near-term visibility but sales ramp up to be expected in H2
Nanologica Q1 2025: Initial comments
Nanologica Q4 2024: Stepping into the next phase
Nanologica Q4 2024: Initial comments
Research note: Nanologica Bags another order
Research note: Nanologica: Fourth Order from GLP-1 Customer in China
Research update: Nanologica Q3 2024 – Poised for harvest season?
Nanologica Q3 2024: Initial comments
Research update: Nanologica Q2 2024: Improvement in production
Research note: Nanologica Q2 2024: Eyes on the customer evaluations
Nanologica Q1 2024: Mixed start of the year
Nanologica Q4 2023: Strong outlook for 2023
Good news often comes in pairs
Nanologica: SEK 3.6m order for non-silica based purification media
Redeye Research Report – Q3 2023 Untapped Potential Ahead
Nanologica AB Q3 2023: Soft sales but EBIT in line
Delivery for full scale production